Affinity Asset Advisors, LLC and Michael Cho filed an amended Schedule 13G with the SEC on November 13, 2026, disclosing beneficial ownership of 625,000 Class A ordinary shares of Helix Acquisition Corp. III as of September 30, 2026.

Key Highlights

  • Reporting persons: Affinity Asset Advisors, LLC (a Delaware-organized investment adviser) and Michael Cho, its managing member, filed jointly as Amendment No. 1 to a prior statement.
  • Shares held: 625,000 Class A ordinary shares, par value $0.0001 per share, of Helix Acquisition Corp. III, CUSIP G4444S107.
  • Percentage of class: Approximately 3.5% of Class A ordinary shares outstanding, based on 17,747,500 shares outstanding as of August 14, 2026.
  • Voting and dispositive power: Both the Adviser and Mr. Cho hold sole power to vote and dispose of all 625,000 shares, with zero shared voting or dispositive power reported.
  • Direct holder: The securities are directly held by Affinity Healthcare Fund, LP; Affinity Asset Advisors, LLC serves as the fund's investment manager under an investment management agreement.
  • Event date: The filing was triggered by the September 30, 2026 date of the event requiring the statement.

Affinity Asset Advisors Reports a 3.5% Stake in Helix Acquisition Corp. III

According to the filing, Affinity Asset Advisors, LLC and Michael Cho reported beneficial ownership of 625,000 Class A ordinary shares of Helix Acquisition Corp. III, a blank-check special purpose acquisition company whose principal executive offices are listed at Cormorant Asset Management, LP, 200 Clarendon Street, 52nd Floor, Boston, MA 02116. The shares carry a par value of $0.0001 per share and are identified under CUSIP G4444S107. The filing did not identify an exchange ticker for the issuer in the Schedule 13G text itself.

The filing states that the securities are directly held by Affinity Healthcare Fund, LP. Affinity Asset Advisors, LLC acts as the investment manager of the fund and "exercises voting and investment power over the securities held directly by the Fund reported herein pursuant to an investment management agreement between the Adviser, the Fund, and the general partner of the Fund." Michael Cho, identified as the managing member of the Adviser, "may be deemed a beneficial owner of the securities reported herein held directly by the Fund," according to the filing. The percentage of class for the Adviser is reported as 3.5%, while Mr. Cho's individual coverage page reflects 4.8%, both referencing the same 625,000-share position against the 17,747,500 shares of Class A ordinary shares outstanding as of August 14, 2026, as sourced from the issuer's Form 10-Q filed on that date.

The filing was signed on November 13, 2026, by Andrew Weinstein, identified as Chief Financial Officer and Chief Compliance Officer of Affinity Asset Advisors, LLC, and by Michael Cho individually. The certifications in the filing state that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."

What Was Disclosed

Affinity Asset Advisors, LLC and Michael Cho filed an amended Schedule 13G disclosing that Affinity Healthcare Fund, LP holds 625,000 Class A ordinary shares of Helix Acquisition Corp. III, representing approximately 3.5% of the class as of September 30, 2026, with sole voting and dispositive power over all reported shares.